Scientists find a way to reverse brain aging

 Ask your competent? doctor to find out what this molecular switch is so you can research it since YOUR DOCTOR WILL DO NOTHING!

Demand your doctor give you a protocol on NAD.

Scientists find a way to reverse brain aging

For decades, brain aging sounded like a one-way street: neurons slow down, memory slips, and the best anyone could hope for was to delay the decline. A wave of new research is challenging that assumption, suggesting that at least some aspects of cognitive aging can be pushed into reverse, not just gently slowed. Instead of a single miracle cure, scientists are uncovering a toolkit of biological switches, lifestyle levers, and targeted therapies that together hint at a future in which an older brain can regain some of its youthful flexibility.

I see a pattern emerging across these studies: the aging brain is far more plastic, and far more responsive to intervention, than the old narrative allowed. From molecular “master switches” that reset cellular programs, to behavioral strategies like intensive language learning and structured memory training, the evidence points toward a new, more hopeful definition of what it means to grow older with a sharp mind.

The new science of a “reversible” aging brain

The most provocative idea in this field is that brain aging is not a single, irreversible process but a collection of changes that can be dialed up or down. Some teams are focusing on the cellular machinery that controls how neurons repair themselves, clear waste, and maintain synapses. When those systems falter, cognition suffers; when they are restored, at least in early experiments, older brains begin to behave more like younger ones. That shift in framing, from inevitable decline to potentially adjustable biology, is what makes recent findings feel so consequential.

 Related video: Study identifies protein that could help protect memory as we age (WKYC-TV Cleveland)

One widely shared example comes from researchers who describe finding a molecular “master switch” that appears to govern key aspects of brain aging. In social media posts summarizing their work, they report that when this switch was experimentally flipped in older brain cells, markers of aging reversed and youthful patterns of activity re-emerged, a claim that has fueled intense interest in a possible master switch of brain aging. While the details are still being scrutinized and the work remains far from clinical use, the concept aligns with a broader body of peer‑reviewed research showing that age-related changes in gene expression and synaptic function are not fixed, but can be modulated under the right conditions.

How learning reshapes the aging brain

One of the clearest demonstrations that older brains can be remodeled comes from studies of intensive learning. When older adults take on demanding new skills, such as mastering a foreign language, their brains respond with structural and functional changes that look strikingly youthful. Imaging work has shown that language learners in later life can increase gray matter density and strengthen white matter tracts in regions tied to memory and attention, suggesting that the act of sustained learning itself can roll back some of the neural signatures of aging.

In reports on cognitive training, researchers describe how older volunteers who committed to rigorous language courses showed measurable gains in processing speed and working memory, along with brain scans that resembled those of much younger participants, an effect highlighted in coverage of learning a new language and brain aging. The implication is not that vocabulary drills are a magic pill, but that the brain’s plasticity can be reawakened when it is pushed beyond routine habits. I read these findings as a strong argument for treating challenging education in later life less as a hobby and more as a serious, evidence-backed intervention.

Memory, synapses, and the mechanics of cognitive repair

Behind the scenes of any cognitive comeback is a microscopic drama at the level of synapses, the junctions where neurons communicate. Age tends to erode the strength and number of these connections, which is why memory often feels less reliable over time. Experimental work in animals and humans has shown that when synaptic plasticity is restored, memory performance can rebound, sometimes dramatically. That is where a growing set of molecular and behavioral interventions is converging: on the machinery that stabilizes new memories and preserves old ones.

Researchers studying the biology of memory formation have zeroed in on how specific signaling pathways and structural proteins support long‑term storage, and how those systems falter with age. Detailed reviews of synaptic mechanisms describe how long‑term potentiation, dendritic spine density, and activity‑regulated genes can be manipulated to enhance recall, with one open‑access paper on synaptic plasticity and memory laying out the case that these processes remain surprisingly malleable in older brains. In parallel, work at Virginia Tech has highlighted how targeted interventions can improve memory performance in older animals by strengthening specific circuits, with one team reporting that carefully timed stimulation of learning-related pathways led to more durable recall in experiments on improving memory in aging models. Taken together, these lines of evidence suggest that memory decline is not a simple fade-out but a problem of maintenance that can, at least in part, be repaired.

Evidence that cognitive decline can be pushed into reverse

For people already experiencing age-related forgetfulness, the key question is whether any of this science translates into real-world gains. Some of the most encouraging data come from structured programs that combine lifestyle changes, cognitive training, and close monitoring of health markers. In these settings, older adults who were already noticing slips in memory have, in some cases, shown not just stabilization but measurable improvement in cognitive scores, hinting that decline can be nudged back toward baseline when multiple levers are pulled at once.

One report aimed at older readers describes how participants over 65 engaged in a mix of brain exercises, physical activity, and diet adjustments, and then saw objective gains in attention and recall that researchers interpreted as a partial reversal of age-related decline, a finding summarized in coverage of how scientists discovered you can reverse brain aging after 65. In a separate line of work, scientists have used advanced imaging and blood biomarkers to track how interventions affect the brain’s biological age, reporting that certain regimens can shift those measures in a younger direction, as described in a recent release on reversing brain aging signatures. I read these converging results as cautious but real evidence that, under the right conditions, the trajectory of decline is not fixed.

Cellular rejuvenation and the role of NAD

While behavioral strategies work from the outside in, another front in the effort to rejuvenate the brain starts at the level of cellular metabolism. A central player in that story is nicotinamide adenine dinucleotide, or NAD, a molecule that helps power energy production and DNA repair. Levels of NAD tend to fall with age, and that drop has been linked to impaired mitochondrial function and increased vulnerability to neurodegeneration. Restoring NAD has therefore become a major focus for researchers who want to reset the aging clock inside neurons themselves.

Scientists at Stanford and elsewhere have reported that boosting NAD in aging brain cells can improve their ability to clear damaged proteins, maintain synapses, and resist stress, findings that have been translated into practical guidance on how to take care of aging brain cells. In these accounts, interventions that support NAD levels, including specific precursors and lifestyle strategies, are framed not as cosmetic tweaks but as ways to restore fundamental housekeeping functions that keep neurons youthful. While clinical trials are still sorting out which approaches are safe and effective at scale, the mechanistic logic is compelling: if you can restore the cell’s energy and repair systems, you give the brain a better shot at rebuilding itself.

What brain training and public health messaging get right

Alongside lab-based work, a parallel ecosystem of brain training programs and public health campaigns has tried to translate the science into everyday habits. Some of these efforts are more evidence-based than others, but the best of them share a few core principles: they emphasize sustained, progressively challenging mental activity; they pair cognitive work with physical exercise and sleep hygiene; and they treat social connection as a non‑negotiable ingredient in brain health. When those elements come together, the result is less a quick fix and more a long-term training plan for neural resilience.

Public-facing videos and explainers have helped popularize this message, walking viewers through how targeted exercises can strengthen attention, working memory, and processing speed in older adults. One widely viewed segment on brain training for seniors illustrates how structured tasks can be scaled to different ability levels, while another video on neuroplasticity and aging breaks down the science of how repeated practice reshapes circuits. I see these efforts as imperfect but useful bridges between complex lab findings and the daily routines that actually determine whether an older brain is being challenged enough to change.

Limits, risks, and what still counts as unverified

For all the excitement around rejuvenation, it is important to be clear about what the evidence does not yet show. Most of the most dramatic reversals have been observed in animal models or in small, carefully selected groups of human volunteers. Many interventions that look promising in mice fail to deliver in large, diverse clinical trials. Some claims circulating online about instant cures or guaranteed reversal of dementia are not supported by the peer‑reviewed literature and remain unverified based on available sources. The brain is not a simple machine that can be reset with a single pill or switch.

Responsible coverage has started to reflect this nuance, highlighting both the potential and the caveats. One recent news feature on aging and brain health underscores that while lifestyle and emerging therapies can meaningfully shift risk and performance, they do not erase the influence of genetics, early life experiences, or broader social determinants of health. I find that tension instructive: the science is opening doors to genuine rejuvenation in specific domains, but it is not rewriting every rule of biology. For now, the most realistic path to a younger-feeling brain combines ambitious but grounded expectations with a willingness to engage in the slow, daily work of learning, moving, and caring for the cells that carry our memories.

More from MorningOverview

• Did archeologists find 10-foot giants in Nevada cave?
• Astronomers track object entering solar system at impossible speed
• Toyotas water powered engine could signal the fall of EV’s
• Giant underground structures uncovered on mars by NASA

Researchers detail habits that could prevent cognitive decline

 Guidelines NOT protocols; so ask your competent? doctor for EXACT PROTOCOLS! You do want to blame your doctor for that decline if the protocols are wrong, right?

Researchers detail habits that could prevent cognitive decline

Around 7.2 million Americans are currently estimated to have Alzheimer's disease,and experts such as those at the National Health Institute say that number could grow to 13.8 million by 2060. As researchers say that indicates clinicians will face "major challenges" in coming years, they are urging people to take a closer look into the lifestyle habits that could help prevent cognitive decline.

While deaths from cardiovascular disease have declined since 2000, deaths from Alzheimer's disease have surged by more than 140%," Dr. Charles H. Hennekens, a professor of Medicine and Preventive Medicine at the Florida Atlantic University Schmidt College of Medicine, told Science Daily. "At the same time, it is estimated that up to 45% of dementia risk could be attributed to modifiable lifestyle and environmental factors."

Hennekens is one of the co-authors of a commentary in "The American Journal of Medicine" that details some of these, which include: physical inactivity; unhealthy diets; obesity and alcohol consumption. Also included are medical conditions like dyslipidemias, hypertension, diabetes and depression as well as social isolation and intellectual inactivity.

On the flip side, there are "therapeutic lifestyle" changes that could help decrease cognitive decline in elderly patients that have been proven to help those with cardiovascular disease as well as other illnesses, researchers wrote. 

 Related video: How to avoid dementia: 8 easy habits that doctors say protect your memory (Woman's World)

These changes include physical activity, adhering to diets like the Mediterranean or DASH diet, and not smoking. 

"Therapeutic lifestyle changes, if demonstrated to be beneficial, would have major clinical and public health implications in reducing cognitive decline in the US and worldwide," researchers said in the commentary. "This possibility is of even greater importance given the interrelationships of cognitive decline with increasing age as well as the increasing proportion of U.S. and other populations of the elderly."

Researchers highlighted the results of the Protect Brain Health Through Lifestyle Interventions to Reduce Risk, or POINTER, trial, where 2,111 men and women between 60 and 79 years old who were at high risk for cognitive decline because of risk factors were given either a "high intensity lifestyle intervention" or a self-guided program.

Those in the high intensity lifestyle intervention group had meetings in person, professional guidance and accountability measures, while the ones who were self-guided had educational materials and "general support." Those in the former group, during the POINTER trial, "demonstrated statistically significant and clinically important improvements in global cognition," particularly when it came to planning, attention and problem solving. Another trial, Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER,) had similar results. 

"There are implications for clinical practice, public health, and government policy, as well as further research," researchers wrote. "Clinicians will now be armed with lifestyle-based changes to reduce cognitive decline. In addition, public health practitioners may also add to their programs based on the study designs of POINTER and FINGER to maintain brain health, complementing pharmacologic approaches."

Not only can these findings be beneficial from a health perspective - researchers said they also could lead to cost savings. Early attention to risk factors of dementia could reduce people's medical and caregiving costs, as well as the "expensive costs of the newly developed pharmacologic agents," some of which offer modest benefits but side effects including "loss of appetite, nausea, vomiting, headache, fatigue and restlessness," researchers noted.

"While more research is needed, the current totality of evidence supports a clear path forward: invest in lifestyle-based strategies to protect brain health," Hennekens said to Science Daily. "Doing so will not only benefit individuals at risk but also serve as a powerful tool for reducing national and global health care burdens related to cognitive decline."

The post Researchers detail habits that could prevent cognitive decline appeared first on Straight Arrow News.

New Blood Thinners Could Help Slow Cognitive Decline in Alzheimer's, Study Finds

 With your risk of dementia post stroke, just maybe you want your doctor to be competent in this! Up to you to ensure competence. 

Your doctor is responsible for preventing this! Is s/he willing to prevent this?

1. A documented 33% dementia chance post-stroke from an Australian study?   May 2012.

2. Then this study came out and seems to have a range from 17-66%. December 2013.`    

3. A 20% chance in this research.   July 2013.

4. Dementia Risk Doubled in Patients Following Stroke September 2018 

The latest here:

New Blood Thinners Could Help Slow Cognitive Decline in Alzheimer's, Study Finds

A new study says this simple change may reduce dementia risk by 50%

 

Until my spasticity is cured I'll never become a 'super mover'. Which means your competent? doctor has to have other protocols that prevent dementia.

A new study says this simple change may reduce dementia risk by 50%

By this point, we have all heard about the health benefits of walking—from helping manage blood sugar to boosting mood. However, a new study shows a simple change in how you walk may reduce your dementia risk by 50%—and it has nothing to do with walking 10,000 steps per day or for 15 minutes after every meal. Spoiler alert: It has to do with your pace.

The study published in Neurology on July 14 analyzed data from seven studies. Five were aging studies from the Health and Retirement Study International Network of Studies (HRS-INS) that involved approximately 4,000 older adults with an average age of about 84. The other two were smaller studies (the LonGenity Study and RUSH Memory Aging Project (RUSH MAP)) of adults ages 80 and older. The researchers used brain scans or examined post-mortem brain tissue.

"We studied adults aged 80 and older to identify a unique group we call ‘super movers’—people whose walking speed is comparable to that of adults in their 50s and 60s," says Joe Verghese, M.D., the head neurologist behind the new research and chair of neurology at Renaissance School of Medicine at Stony Brook University. "We then compared their cognition with that of other adults the same age to understand what makes them different."

 Related video: New study examines dementia risk factors (WKRN Nashville)

What the study found

The results were drawn from follow-up periods between approximately 3.5 to 5.5 years and showed that the "super movers" had about a 50% lower risk of developing cognitive impairment than their peers and 60% less likely to report a diagnosis of Alzheimer’s disease or another dementia. They also had a slower decline in memory and thinking skills over time, which was measured by memory recall, processing speed, and mental flexibility tests.

"Even more surprisingly, despite having better cognitive function, they had similar levels of dementia-related brain pathology which suggests they may have resilience mechanisms that protect the brain from developing cognitive symptoms," says Dr. Verghese.

For example, “super mover” brains had bigger hippocampi (the part of the brain responsible for memory functioning), according to Erica Weiss, Ph.D., a clinical neuropsychologist on the study and associate professor of neurology at Albert Einstein College of Medicine.

The takeaway

This new research not only supports the idea that you should walk more, but that you should pick up the pace if you can. "Gait speed at 80 years of age and older is one of the best single predictors of overall physiological health because it integrates cardiovascular, musculoskeletal, neurological, and metabolic function simultaneously," says Nir Barzilai, M.D., one of the study’s researchers and a professor from the department of genetics at the Albert Einstein College of Medicine. "What this study captures isn't just ‘movement is good for the brain’; it's that whole-body biological aging pace shows up in how you walk, and that same pace protects every system."

Staying physically active and maintaining mobility should be viewed as an important part of brain health, adds Dr. Verghese. "Regular exercise, managing chronic medical conditions, and paying attention to changes in walking or balance may help preserve both physical independence and cognitive function as we age," he says.

Aging Brains Maintain Robust Language Networks Despite Cognitive Decline

 How will your competent? doctor exploit this to prevent cognitive decline posts stroke? Oh NO, your doctor KNOWS NOTHING ABOUT PREVENTING COGNITIVE DECLINE!  Your incompetent board of directors doesn't know how to hire competent persons! You'll have to reconstitute the hospital so your children and grandchildren get a good recovery from their strokes!

Aging Brains Maintain Robust Language Networks Despite Cognitive Decline

Summary: While executive functions like memory and problem-solving naturally decline as we age, new brain imaging research reveals that the neural network responsible for language remains preserved and fully functional. The study suggests that highly specialized brain regions are more resilient to aging compared to general cognitive networks.

Key Facts:

• Brain activity in the language processing network is nearly identical between younger (ages 17–39) and older (ages 41–80) adults.
• The “multiple demand network,” which governs executive control tasks like working memory, showed significantly reduced synchronization and weaker activation in older adults.
• Language skills typically remain stable and can even improve with age, as older adults continually build their vocabularies—functioning much like a large language model trained on a lifetime of data.

Source: Massachusetts Institute of Technology

As human beings age, many cognitive functions naturally decline. Brain scans have consistently shown age-related deterioration in neural networks responsible for executive functions, working memory, and problem-solving. But when it comes to language, the aging brain tells a completely different, highly resilient story.

Barring neurological conditions such as stroke or dementia, most older adults retain excellent language skills. In fact, many individuals experience linguistic improvement as they accumulate a richer vocabulary throughout their lives.

A newly published brain imaging study—a collaboration between researchers at MIT and Boston University—has finally uncovered the neural mechanisms behind this phenomenon.

By analyzing the brains of older and younger adults, scientists discovered that activity in the brain’s language processing network remains remarkably stable as we age. When performing language tasks, older adults exhibited neural activation patterns almost completely identical to those seen in younger adults.

“In the language network, we couldn’t find any differences between older and younger groups,” says Anne Billot, a lead author of the study and currently a postdoc at Harvard University. “In contrast, the executive system showed decline across almost all of the measures. The network synchronization declined in older adults, the extent of activation was reduced, and the magnitude of activation was reduced as well.”

The research team divided participants into two cohorts: a younger group (ages 17–39) and an older group (ages 41–80). The participants engaged in carefully designed tasks to isolate two distinct brain systems: the “multiple demand network” (responsible for flexible problem solving and executive control) and the language network.

To trigger the multiple demand network, participants performed a spatial memory task where they had to remember the location of squares in a grid. As expected, older adults displayed weaker, less synchronized activation in these frontal and parietal brain regions compared to younger participants.

However, when subjects listened to stories and read sentences to trigger the language network, the results were strikingly different. Both younger and older adults demonstrated equivalent levels of spatial distribution and neural activity. When encountering unusual grammar or unfamiliar words, both groups showed the same spike in sensitivity and heightened neural response.

“We have previously used similar kinds of materials to show that young adults show strong sensitivity to these points of linguistic difficulty: activity in the language areas goes up. Here we found that in older adults, you also see this sensitivity, which suggests that there’s nothing fundamentally different about how they process language,” explains Evelina Fedorenko, an MIT associate professor of brain and cognitive sciences and senior co-author of the study.

Unlike the multiple demand network, which operates as a flexible, general-purpose resource vulnerable to aging, the language network specializes in accumulating knowledge.

“Vocabulary keeps increasing as long as people have been measuring, which makes sense. People get exposed to more and more language, and older people sometimes start reading more, so they get an extra boost — it’s like a large language model trained on increasingly more data,” Fedorenko notes.

These findings suggest that highly specialized regions of the brain may be fundamentally shielded from the normal wear and tear of aging, preserving our ability to communicate effectively throughout our entire lifespan.

Editorial Notes:

• This article was edited by a Neuroscience News editor.
• Journal paper reviewed in full.
• Additional context added by our staff.

About this Aging Research:

• Author / Media Contact: Sarah McDonnell
• Source: Massachusetts Institute of Technology (MIT)
• Contact Info: Sarah McDonnell
• Image Credit: Neuroscience News
• Original Research: Open access. “Preserved topography, lateralization, selectivity, and functional connectivity of the language network in older brains” by Anne Billot, Niharika Jhingan, Swathi Kiran, Evelina Fedorenko, et al. Nature Communications. Published August 24, 2026.
• https://doi.org/10.1038/s41467-026-76598-x

Sex-Specific Associations Between Blood Pressure and Cognitive Decline

 Have your competent? doctor determine what this means for your cognitive ability.

Sex-Specific Associations Between Blood Pressure and Cognitive Decline

Faster declines in systolic blood pressure were associated with simultaneous declines in global and domain-specific cognition among older women, but not older men.Faster declines in systolic blood pressure are associated with faster simultaneous declines in cognition among older women, but not men, according to a study published in the Although changes in blood pressure (BP) and cognition are common with aging, the relationship between longitudinal changes in BP and cognitive function, particularly by sex, remains poorly understood.  Researchers therefore evaluated whether simultaneous changes in BP and cognition differed between older women and men using data from 5 ongoing longitudinal, community-based cohorts: Religious Orders Study (ROS)Rush University’s Memory and Aging Project (MAP) Minority Aging Research Study (MARS) Rush University’s Alzheimer’s Disease Center Clinical Core (ClinCore) Latino Core (LATC) Adults (N=4719) who underwent annual BP and cognitive assessments were evaluated for longitudinal changes in both. The women (n=3502) and men (n=1217) had a mean (SD) age of 76.7 (7.8) and 76.8 (7.5) years, respectively. Among women and men, 62.9% and 70.3% were White, respectively; mean (SD) BMI was 28.3 (5.9) and 27.93 (4.3) kg/m², and 58.1% and 50.1% had a history of hypertension, respectively.Understanding these sex-specific associations may help advance the understanding of drivers behind sex differences in cognitive decline. Over a mean (SD) 8.7 (5.7)-year follow-up, systolic BP, diastolic BP, global cognition, working memory, semantic memory, episodic memory, perceptual speed, and visuospatial ability all declined significantly (all P <.01). Men experienced a greater decline in diastolic BP than women (adjusted estimate, −0.031 vs −0.011; P <.001), whereas no sex differences were observed in rates of decline for systolic BP or cognitive measures. Among women, higher systolic BP at baseline was significantly correlated with lower semantic memory, perceptual speed, and visuospatial ability scores (r range, −0.07 to −0.05; all P ≤.04). Faster declines in systolic BP over time were correlated with faster declines in global cognition and all 5 cognitive domains (r range, 0.20-0.32; all P <.001).

Diastolic BP was correlated with global cognition, working memory, and visuospatial ability among women (r range, -0.06 to -0.05; all P ≤.03), whereas changes in diastolic BP were not correlated with changes in any cognitive outcomes (all P ≥.35).

Among men, higher systolic BP at baseline was significantly correlated with lower global cognition, perceptual speed, and visuospatial ability (all r, −0.08; all P ≤.04). Changes in systolic BP were not correlated with changes in any cognitive outcomes (all P ≥.23).

Diastolic BP was correlated with global cognition, episodic memory, and perceptual speed among men (r range, -0.11 to -0.10; all P <.01), while increasing diastolic BP was correlated with faster declines in working memory (r, −0.18; P =.03).

Sensitivity analyses showed that the associations between changes in BP and cognition were robust after adjustment for BMI, race/ethnicity, apolipoprotein E (APOE) ε4 status, study cohort, and number of follow-up visits. Excluding participants who developed dementia within 3 years of baseline and adjusting for death during follow-up also did not alter the findings.

In age-stratified analyses, the relationships between changes in BP and cognition were primarily observed later in life. Among participants older than 70 years, associations between declining systolic BP and global and domain-specific cognition were comparable to or larger than those in the primary analyses. Among participants aged 70 years and younger, these relationships were attenuated.

Study limitations included the predominantly White study population, the inability to determine whether declining BP precedes cognitive decline or vice versa, the lack of data on hypertension control, and the possibility that a floor effect in cognitive scores among men contributed to the observed sex differences.

“As women experience a disproportionate burden of both hypertension and cognitive decline in late-life, declining systolic BP, a routine clinical measure, may serve as an important indicator of concurrent cognitive decline in older women,” the researchers concluded. They continued, “Understanding these sex-specific associations may help advance the understanding of drivers behind sex differences in cognitive decline.”

References:

Baumgartner NW, Capuano AW, Barnes LL, Bennett DA, Arvanitakis Z. Sex differences in the association of simultaneous decline in blood pressure and decline in cognition during aging. Ann Neurol. Published online July 7, 2026. doi:10.1002/ana.78280

An Alzheimer’s drug cut expected cognitive decline roughly in half. It didn’t target amyloid

 You may need this; do you have a competent? doctor ready?

Your risk of dementia, has your doctor told you of this?  Your doctor is responsible for preventing this! Is s/he willing to prevent this?

1. A documented 33% dementia chance post-stroke from an Australian study?   May 2012.

2. Then this study came out and seems to have a range from 17-66%. December 2013.`    

3. A 20% chance in this research.   July 2013.

4. Dementia Risk Doubled in Patients Following Stroke September 2018 

The latest here: 

An Alzheimer’s drug cut expected cognitive decline roughly in half. It didn’t target amyloid

Researchers say the oral drug LM11A-31 slowed the decline of brain-network function in a small trial, pointing to a potential broader strategy for treating Alzheimer’s.

Could the key to treating Alzheimer’s be protecting the brain’s wiring? Potentially.

Last month, at the Alzheimer’s Association International Conference in London, Indiana University and the biopharmaceutical company PharmatrophiX presented findings that an oral drug called LM11A-31 slowed the decline of brain-network function in people with mild-to-moderate Alzheimer’s. The results, which were drawn from brain scans of 159 trial participants, point to a treatment strategy that looks well beyond the field’s longtime focus on amyloid, according to a press release.

For years, most Alzheimer’s drug development has centered on clearing amyloid plaques, and more recently tau tangles. But researchers say it’s more complicated than that.

“The main reason [to look further] is that pure amyloid beta plaque and tau tangle Alzheimer’s disease is rare,” Maria C. Carrillo, chief science officer at the Alzheimer’s Association, told Inc. The association awarded PharmatrophiX a $600,000 grant in 2013 to run an early safety trial of the oral drug LM11A-31. 

In most biologically confirmed cases, she told Inc., it’s actually “mixed dementia,” with other proteins and vascular damage present alongside the two hallmark lesions. That complexity is pushing scientists toward treatments that protect the brain itself. 

“Alzheimer’s is a complex disease driven by multiple interacting mechanisms,” Aaron Burstein, head of search and evaluation at the Alzheimer’s Drug Discovery Foundation, told Inc. The foundation has backed the drug’s lead inventor, Frank Longo, since 2000 and was an early investor in PharmatrophiX. 

“Amyloid is a validated target, but it is unlikely to be the only one,” he said.

The oral drug LM11A-31 focuses on the synapses, the junctions where brain cells communicate. It targets a receptor called p75, and according to the release, earlier studies have suggested it can make synapses more resilient to the damage caused by both amyloid and tau.

The new part is the ability to measure whether that’s actually working. The Indiana University team, led by Paul Territo, processed metabolic PET scans to build “network maps” of how efficiently different brain regions communicate.  Related video: Groundbreaking Alzheimer's treatment offers patients new hope (FOX 35 Orlando) 

“Alzheimer’s disease is not simply a disease of individual brain regions. It is a disease of disrupted brain networks,” Territo said in the release.

The analysis found dose-dependent effects, with the strongest benefits in patients on the higher 400-milligram dose, along with distinct patterns between men and women. It builds on earlier results, in which the drug cut the expected progression of cognitive decline roughly in half.

“Protecting synapses has become a central therapeutic goal,” Burstein told Inc. “This type of approach could support a precision medicine framework in which treatments target different aspects of the disease and are ultimately combined based on each patient’s biology.”

Implications for the future of Alzheimer’s treatments

Everyone involved has been careful to call the signal a starting point.

“LM11A-31’s potential will need to be confirmed in a larger clinical trial,” Burstein said. 

Investors, clinicians, and patients, he added, will want consistent evidence that the drug slows cognitive and functional decline in ways that are meaningful in daily life and sustained over time.

Carrillo agreed that the next step runs through regulators. She said that confirming the signal means a trial showing that over one to two years the treatment “slows or perhaps even stops the memory decline in comparison to a placebo group,” on terms agreed upon with the FDA.

In the release, PharmatrophiX said more planning is underway for that larger Phase 2b/3 trial. If it succeeds, LM11A-31 could become one more tool used alongside amyloid drugs.

“We know that the current approved treatments for early Alzheimer’s disease are just the beginning,” Carrillo told Inc. “More treatments are coming, each improving on the earlier treatments.”

PharmatrophiX did not respond to Inc.’s request for comment. 

This post originally appeared at inc.com.

“Click here to subscribe to the Inc. newsletter: inc.com/newsletters"

Simple biological age score flags higher cognitive decline risk in older adults

 

 A competent? doctor would be testing your biological age and have EXACT PROTOCOLS to reduce it! Did your doctor fail at that?

Simple biological age score flags higher cognitive decline risk in older adults

A biological age score calculated from just four routinely available measures was linked to future cognitive problems, suggesting that how the body ages may reveal risks that chronological age alone can miss.

A recent study published in the journal Scientific Reports examined the relationship between light BioAge and the risk of cognitive impairment and cognitive decline in middle-aged and older adults, utilizing data from a large Chinese longitudinal cohort.

Cognitive Impairment and Biological Aging

Cognitive impairment describes a decline in mental abilities, including memory, reasoning, attention, and language, which goes beyond typical age-related changes. It is prevalent in older adults and can range from mild deficits to severe loss of independence, with dementia representing the most severe and disabling manifestation.

Mild cognitive impairment affects approximately 15.6% of community-dwelling adults aged 50 years and older worldwide, while prevalence in China has been estimated at 19.6%. Its effects extend beyond cognition, impacting psychological well-being, social participation, physical function, and contributing to a substantial economic burden.

Age is the primary risk factor, but others include cardiovascular diseases, hypertension, obesity, diabetes, smoking, depression, physical inactivity, and low educational level. Aging triggers changes in the brain, including hippocampal atrophy, imbalance in amyloid beta, increased inflammation, and neuronal vulnerability in memory-related areas, which may contribute to cognitive impairment.

However, individuals age at different rates, and chronological age does not always reflect true biological aging. Several biological aging models have been developed, such as DNA methylation clocks and organ-specific aging measures, but these often require complex biomarkers and calculations, limiting their practical use.

A simplified biological aging index, termed light BioAge, was recently developed. It incorporates four metrics: chronological age, creatinine, blood glucose, and C-reactive protein (CRP). This index is straightforward to calculate and demonstrates strong associations with mortality and frailty. However, the relationship between light BioAge and the risk of cognitive impairment has not been clearly established.

Examining Light BioAge and Cognitive Outcomes in a Chinese Cohort

Scientists assessed associations between light BioAge and cognitive outcomes using data from the China Health and Retirement Longitudinal Study (CHARLS), a nationally representative cohort of Chinese adults aged 45 and older spanning 2011–2020. CHARLS collected detailed information on health, socioeconomic status, and pension security.

CHARLS used a multistage, stratified, cluster-randomized design to recruit approximately 17,000 participants from 150 counties and 450 communities. Data included demographics, health status, physical activity, medical history, lifestyle, and laboratory values.

Light BioAge at baseline was the exposure variable. Baseline data were collected in 2011–2012, with follow-ups in 2013, 2015, 2018, and 2020. Only participants from 2011–2012 without baseline cognitive impairment or memory-related diseases, and with the data needed to calculate light BioAge and assess cognition during follow-up, were included.

The primary outcome was new-onset cognitive impairment during follow-up. Secondary outcomes included declines in mental intactness and episodic memory. Cognitive function was measured using a 0–31-point scale, with higher scores indicating better function. The assessment comprised two components: episodic memory (0–20 points; immediate and delayed word recall) and mental state (0–11 points; orientation, calculation, and drawing tasks). Cognitive impairment was defined as a total score below 11, while declines in mental intactness or episodic memory were defined using changes from baseline, with difference scores below the lowest quartile classified as a decline. This survey-based definition of cognitive impairment was not equivalent to a clinical diagnosis of mild cognitive impairment or dementia.

Associations between light BioAge and cognitive decline were analyzed using Cox regression, adjusting for confounders. Subgroup, non-linear, and sensitivity analyses were also performed.

Higher Light BioAge Remains Associated with Poorer Cognitive Outcomes

A total of 17,272 participants aged 45 years or older were included in the 2011-2012 CHARLS. After excluding individuals with baseline cognitive impairment, memory-related diseases, missing light BioAge data, or no cognitive assessment data during any of the four follow-up surveys, 4,818 participants were included in the analysis. During follow-up, 23.72% developed cognitive impairment, 40.70% showed a decline in mental intactness, and 35.14% experienced episodic memory decline.

Analysis revealed that higher light BioAge remained associated with increased risks of cognitive impairment, episodic memory decline, and reduced mental intactness after controlling for chronological age and other potential confounders. Because chronological age is itself a component of light BioAge, the authors cautioned that this should not be interpreted as an effect entirely independent of chronological age. Notably, individuals with light BioAge ≥56.82 years had substantially higher risks of cognitive impairment and episodic memory decline than those with light BioAge <42.45 years.

Sensitivity analyses supported these findings, indicating that higher light BioAge remained associated with poorer cognitive outcomes. No significant non-linear associations were found. Adding light BioAge to multivariable models produced small but statistically significant improvements in predictive performance across all three cognitive outcomes, while a separate analysis found that combining age with light BioAge better predicted cognitive impairment than age alone.

Exploratory subgroup analyses further suggested that the association between higher light BioAge and cognitive risks persisted across several demographic and health-related groups, although the patterns were not consistent across all subgroups. These results suggest that light BioAge may have potential as an epidemiological marker of cognitive risk, although its additional ability to distinguish individual risk appears modest.

The Potential Predictive Value of Light BioAge for Cognitive Health in Aging Adults

The current study found that higher light BioAge is associated with increased risks of cognitive impairment, episodic memory decline, and reduced mental intactness among middle-aged and older adults.

Light BioAge provided modest additional predictive information, and for cognitive impairment, combining light BioAge with chronological age performed better than age alone. It may serve as a potential epidemiological marker for the early identification of cognitive impairment risk in this population. However, the study does not establish causality, and cognitive impairment was identified using survey-based cognitive testing rather than a clinical diagnosis. 

The authors also noted potential selection bias from extensive participant exclusions and the need to validate the findings in other populations before light BioAge can be considered for routine clinical risk assessment.

Journal reference:

• Qiu, W. et al. (2026). Association between light BioAge and cognitive impairment risk in middle-aged and elderly people: A retrospective cohort study. Scientific Reports. DOI: 10.1038/s41598-026-65251-8, https://www.nature.com/articles/s41598-026-65251-8

Scientists just discovered a new brain phase between 50 and 75. It may help explain cognitive decline

 Have your competent? doctor and hospital get further research going that creates protocols to address this problem! Can't do that? PURE INCOMPETENCE!

Scientists just discovered a new brain phase between 50 and 75. It may help explain cognitive decline

A single-cell study of the hippocampus suggests brain aging is not a steady decline, but a coordinated immune, vascular, and neuronal overhaul.

Scientists at the University of California, San Diego School of Medicine just discovered a new brain phase.

A single-cell study identified a new biological phase the brain may enter between 50 and 75. The research offers new, important insights about brain aging and cognitive decline.

Between the ages of 50 and 75, the cellular landscape of the hippocampus, the brain’s memory region, begins to change. Immune cells get replaced, the genome’s physical structure loosens, and gene regulation is reshaped across multiple cell types. 

The study’s findings, which were published in the peer-reviewed journal Science, suggest that aging is not so much a gradual decline than an active biological overhaul—one that may eventually be a target for treatment.

The researchers looked at individual cells from human hippocampal tissue collected at various points across the adult lifespan. They then mapped gene regulation and three-dimensional genome architecture to produce what Sci Tech Daily called “one of the most detailed accounts yet of how these features change as the human brain ages.”

A changing immune system

One of the most significant shifts the scientists discovered appeared in the microglia—the immune cells that help maintain and protect that brain. In midlife, between the ages of 50 and 75, the microglia that formed during embryonic development declined sharply. The researchers found that cells with similar traits to blood immune cells replaced the missing microglia cells.

Related video: Study identifies protein that could help protect memory as we age (WKYC-TV Cleveland)

Those replacements carried stronger inflammatory signatures, raising the possibility that they help drive the persistent inflammation tied to brain aging. At the same time, cell populations that maintain the blood-brain barrier dropped off substantially.

“Microglia are critical for maintaining brain homeostasis,” Bing Ren, PhD, a corresponding author of the study and scientific director and CEO of the New York Genome Center told Sci Tech Daily. “When these cells fail to perform their housekeeping duties, toxic materials accumulate that can trigger inflammatory processes that may contribute to neurodegenerative diseases.”

Nathan Zemke, PhD, lead author and a principal investigator at the UC San Diego Center for Epigenomics, told Inc. that the immune system shift is directly connected to memory. 

“Between roughly ages 50 and 80, many of the brain’s original immune cells appear to be replaced by immune cells that enter from the bloodstream,” he told Inc. 

Those cells are important for clearing debris and protecting the brain, he added, but the incoming ones carry stronger inflammatory signals, which may contribute to the chronic brain inflammation commonly associated with cognitive decline.

Across several brain cell types, the genome’s three-dimensional structure grew progressively less organized with age. DNA folds into a precise architecture that helps determine which genes a cell can use. As that folding erodes, so does the cell’s control over its own machinery. The researchers suggest it may be a basic feature of brain aging.

That breakdown is what makes the structural changes matter for the mind, Zemke said. “Every type of brain cell relies on a carefully organized set of genetic instructions to perform its specialized role,” he told Inc. “As we age, that organization begins to break down, which may disrupt the genes needed to maintain healthy brain function and cognition.”

Notably, the immune, vascular, and neuronal systems appeared to change together, in a coordinated way. 

“Importantly, this study reveals that aging is not simply a gradual decline, but involves coordinated and dynamic remodeling of immune, vascular, and neuronal systems,” said Xiangmin Xu, PhD, a co-corresponding author and director of the Center for Neural Circuit Mapping at UC Irvine told Sci Tech Daily.”These findings open the door to identifying new therapeutic targets aimed at preserving circuit integrity and brain function across the lifespan.”

Implications for the future of aging research

The findings should also change how professionals think about aging itself, Zemke told Inc. “Many biological changes associated with aging appear to accelerate around age 50, including increased inflammation and reduced cellular energy production,” he said. “However, the timing varies greatly from person to person. Understanding what drives that variation could help explain why some people age more successfully than others.”

The immune-cell shift may carry the greatest significance for Alzheimer’s research. The replacement of the brain’s original immune cells by blood-derived ones occurs during the same window when Alzheimer’s-related changes are thought to begin, Zemke said. The incoming cells show inflammatory features associated with the disease, suggesting the transition could be an important contributor to Alzheimer’s risk.

This post originally appeared at inc.com.

“Click here to subscribe to the Inc. newsletter: inc.com/newsletters"